Factors associated with the severity and complication of patients with malaria hospitalized between 2009 and 2013 in three municipalities of Colombia, case control study by Jesica F. Ramírez et al.
Ramírez et al. Malar J  (2016) 15:514 
DOI 10.1186/s12936-016-1554-5
RESEARCH
Factors associated with the severity 
and complication of patients with malaria 
hospitalized between 2009 and 2013 in three 
municipalities of Colombia, case control study
Jesica F. Ramírez, Beatriz Porras, Elizabeth Borrero and Sandra P. Martínez*
Abstract 
Background: Malaria worldwide annual reported cases range between 250 and 500 million and nearly half a million 
deaths are reported every year. Colombia has a vast expanse of territory with environmental and social conditions 
conducive to malaria transmission, which is the reason why it has second place in Latin America for the number of 
cases of malaria.
Methods: This is a retrospective, paired, case–control study that compares patients with severe malaria and malaria 
patients without mention of complication. Medical records of patients with confirmed malaria diagnosis were 
reviewed. The objective of this study was to identify factors associated with complicated malaria in three municipali-
ties of Colombia during the period 2009–2013.
Results: A total sample of 180 medical records was collected, 60 corresponding to cases and 120 to controls fol-
lowing a 1:2 ratio. From the total sample, 88.33 % (159) of subjects were originally from Tumaco, 7.78 %, most of the 
patients of the study (104) were diagnosed and treated in 2013. Among the laboratory findings, the platelet count 
was found to have statistically significant differences between cases and controls; this was also true for total bilirubin 
value and transaminases. The most prevalent severity finding was clinical jaundice, followed by elevated bilirubin 
(25 %) and elevated transaminases (44.4 %). Thrombocytopenia was found in 11/44 cases (20 %) and only five of 60 
patients (8.3 %) presented severe anaemia. The multivariate analysis showed that a platelet count <100,000 and clini-
cal jaundice not associated with organ failure, were the two variables associated with severe malaria in the patients 
described.
Conclusions: Most of the cases studied, despite meeting criteria of severity, were shown not to be as morbid or 
severe as in other countries. Clinical jaundice and thrombocytopaenia are associated with severe malaria, and they 
can be used by general practitioners or primary care physicians to promptly identify patients who may have severe 
malaria.
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Background
Although other Plasmodium species can cause severe 
disease and death, most of these outcomes are reported 
in Plasmodium falciparum infections. Annual statistics 
of malaria cases worldwide range between 250 and 500 
million, and nearly half a million deaths are reported 
every year. Severe cases and deaths from malaria occur 
mainly in the poorest regions of countries affected with 
social exclusion [1].
Colombia has a vast expanse of territory with environ-
mental and social conditions conducive to malaria trans-
mission, which is the reason why it has earned second 
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place in the number of cases of malaria in Latin America. 
In 2010 an estimate of more than one million cases of 
malaria and 1100 deaths from malaria was made in the 
South and Central American region. Brazil reported the 
highest number of cases (54.4  %), followed by Colom-
bia (13.1  %) and Venezuela (9.3  %). The largest number 
of deaths from malaria reportedly occurred in Brazil, 
Colombia and Dominican Republic [2].
The major complications of malaria described in litera-
ture are cerebral malaria, pulmonary oedema, acute renal 
failure, severe anaemia, bleeding, acidosis and hypogly-
caemia [3]. Cerebral malaria is the presentation of the 
disease which most frequently leads to mortality [4]. It is 
of utmost importance to identify the red flags and sever-
ity-associated symptoms in patients with malaria, so 
these patients can be promptly diagnosed and provided 
with the medical care necessary to prevent fatality. This 
study aims to identify factors associated with severity and 
complications of malaria in three municipalities of the 
Colombian Pacific over a 5-year period.
Methods
This is a retrospective, matched, case–control study 
that compares patients with severe malaria and malaria 
patients without mention of complication. The data 
used in this study were collected from medical records 
of patients with confirmed malaria diagnosis, hospital-
ized between 2009 and 2013, in four different hospitals 
located in endemic areas of the Colombian states of Nar-
iño and Valle del Cauca, covering the municipalities of 
Tumaco, Buenaventura and Cali. The total data collection 
time was 14 months, starting in 2012.
Sample size definition
Considering the findings of the study performed by 
Tobon et al. [5], the proportion of patients with respira-
tory distress was used to calculate the sample size. The 
proportion of patients with respiratory distress con-
sidered for cases was 38 and 14  % for controls. A case/
control ratio of 1:2, confidence level of 95 % and power 
of 90  % were used to design the study. The sample size 
required for the study following these parameters was 60 
cases and 120 controls.
Matching process
Matching of cases and controls was performed consider-
ing year of malaria diagnosis, municipality of origin and 
Plasmodium species. Matching by year of presentation 
and municipality was done to assure that the patient base 
population of cases and controls remained constant. The 
area where the study was conducted has a population that 
is constantly changing and moving in between regions 
due to their economical activities, such as mining, and 
the effect of the armed conflict that affects the area. The 
biggest proportion of cases of severe malaria is reported 
in the young adult population. Given the fact that malaria 
presentations change importantly with age, a decision 
was made to not include the age in the matching process 
so further analysis could be made from the outcomes of 
the study related with the age. A bivariate analysis was 
conducted to determine if the variable age was confound-
ing factor or a factor associated with severity. Due to the 
lack of information regarding previous malaria episodes 
in the medical records reviewed, matching by this vari-
able was not possible.
Data collection
A detailed review of the National System for Public 
Health Surveillance (SIVIGILA) databases from 2009 to 
2012 was performed to identify the medical records of 
cases and controls available to review in each municipal-
ity. Once the data were obtained, a formal request was 
sent to each institution to obtain access to the medical 
records. In order to obtain enough medical records of 
malaria patients, information from malaria public health 
notification forms located in the Public Health and Sta-
tistic Departments of the hospitals were also used.
An on-line instrument in the form of a questionnaire 
was designed as well as a guideline with definitions, inclu-
sion and exclusion criteria, to be used by trained doctors 
to collect the data from the medical records in the desig-
nated areas. The instrument included: personal identifica-
tion, past medical history, history of present illness, clinical 
characteristics, physical examination, diagnosis, paraclini-
cal and parasitological results on admission, treatment, 
and case outcome. The instrument was accessible via 
email, using the SurveyMonkey® tool and was filled using 
mobile devices with internet access to assure real-time 
accessibility and quality control of the data being collected.
To ensure the instrument was filled out correctly, 
three independent reviewers evaluated the quality of the 
information filled out for each medical record, using a 
constructed validation mesh interdisciplinary with the 
statistical unit, and provided feedback to the doctors 
when necessary to correct discrepancies.
Inclusion criteria
Patients with signs or symptoms of malaria, with con-
firmed diagnosis of malaria infection with either Plas-
modium vivax or P. falciparum, made by thick or thin 
smears and treated in the municipalities were included in 
the study.
Exclusion criteria
Cases of sickle cell disease, viral or bacterial infec-
tions and/or other diseases that could explain the 
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clinical presentation, as well as cases that originated from 
a municipality not included in the area of analysis, or 
cases that were transferred from another municipality to 
receive medical care were excluded.
Case definition
Subjects hospitalized between 2009 and 2013, with diag-
nostic confirmation of P. vivax or P. falciparum via thick 
blood smear slides, and with one or more of the clini-
cal or paraclinical criteria mentioned in the Colombian 
National Guidelines for severe malaria, were defined as 
cases, as shown in Table 1.
The Colombian National Guidelines differ from the 
World Health Organization (WHO) guidelines, for severe 
malaria they define hepatic dysfunction as transaminase 
values >40 IU. According to medical literature and WHO, 
malarial hepatic dysfunction is defined as an elevation of 
three times the upper limit of normal transaminase val-
ues. An intermediate value of >80 IU was utilized in this 
study in order to analyse the possibility of proposing a 
new cut-off point for the Colombian guidelines, given the 
low prevalence of hepatic failure and hepatic dysfunction 
in Colombia [6].
Control definition
Patients with clinical malaria diagnosis confirmed by 
thick or thin blood smear slides, proven to be infected 
with P. falciparum or P. vivax, that did not have any of the 
severity criteria mentioned for case definition and were 
proven to be infected and treated in the municipalities, 
were included in the study.
Statistical analysis
In order to identify inconsistencies and extreme values 
in the dataset, an exploration of the variables included 
in the study was performed. A univariate descriptive 
analysis, including the demographic, clinical and labora-
tory data was performed using frequency tables and cen-
tral tendency measures according to the type of variable.
Given the design of the study, paired case control study 
1:2 ratio, paired by year of diagnosis, municipality and 
Plasmodium species, a Student’s t test was performed 
to analyse differences between case and control in the 
numeric variables, and McNemar’s test for categori-
cal variables. Conditional logistic regression was used 
to calculate the odds ratio and 95  % confidence inter-
vals to find association between independent variables 
and severe malaria. In order to find association between 
clinical factors and severe malaria, a multiple conditional 
logistic regression was performed using the variables that 
were found to be statistically significant (P < 0.05) or rel-
evant in the bivariate analysis, controlling confounding 
factors and analysing possible interactions between vari-
ables. Verification that the statistical models complied 
with all the assumptions of the logistic regression was 
also performed.
Variables considered in the statistic bivariate analysis 
and statistical model were: gender, age, place of origin, 
duration of symptoms before admission, symptomatol-
ogy on admission, presence of co-morbidities, days hos-
pitalized, vital signs on admission, thick and thin blood 
smear slide results, physical examination on admission, 
medical treatment received, initial laboratory values, 
pregnancy status, previous history of malaria, and prior 
medical attendance before admission. Statistical analysis 
was processed using STATA® version 12.
Ethical considerations
Ethical approval was granted by the ethics commit-
tee that permitted access to patient medical history and 
data collection for analysis and conversion to a scientific 
manuscript.
Table 1 Severity criteria for severe malaria
* Elevated transaminases >80 UI was the criteria used in this study; which differs from the OMS guideline of transaminases three times the normal range and the 
Colombian Guideline of transaminases >40 UI
Clinical criteria Laboratory criteria
Loss of consciousness or profound coma Haemoglobinuria
Prostration; extreme weakness with inability to walk or sit without assistance Hypoglycaemia (<60 mg/dL)
Inability to feed oneself Metabolic acidosis (plasmatic bicarbonate <15 mmol/L)
Multiple seizures; more than 1 episode in 24 h Hyperlactaemia (lactate acid <5 mmol/L)
Respiratory distress syndrome Severe anaemia (haemoglobin <7 g/dL, haematocrit <21 %)
Circulatory collapse/shock; systolic arterial pressure <80 mmHg in adults 
and <50 mmHg in children
Hyperparasitaemia (>50,000 asexual parasites/μL) with the diagnosis of P. 
falciparum, or mixed infection with P. vivax
Clinical jaundice with signs of vital organ failure Thrombocytopaenia (<50,000 mm3)
Spontaneous haemorrhage Elevated transaminase (>80 IU)*
Pulmonary oedema evidenced through radiography Elevated total bilirubin (>1.5 mg/dL)
Renal insufficiency (serum creatinine level >1.5 mg/dL)
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Results
The total sample collected for cases and controls was 
180, 60 medical records corresponding to cases and 120 
to controls, following a 1:2 ratio. From the total sam-
ple 88.33  % (159) of the subjects were originally from 
Tumaco from which 53 were cases and 106 were controls. 
5.00 % (nine) from Cali, three were cases and six controls, 
and 6.66 % (12) from Buenaventura four were cases and 
eight controls. Regarding the year of medical consulta-
tion, six of the subjects were seen in the emergency room 
in 2009, 17 in 2010, 12 in 2011, 41 in 2012, and 104 in 
2013.
Half of the malaria cases with confirmed severity cri-
teria were women, and the other 50 % were men. For the 
control group, 46.67  % (56) were women and 53.33  % 
were men. As seen in Table 2, the adult population pre-
dominated both in the control and case groups.
Regarding the general system of social security affilia-
tion status, more than 90 % of the cases and controls were 
affiliated at the time of their medical attention, meaning 
that medical attention should be provided to them by law 
in any public health institution.
Medical care
The average number of days hospitalized for the cases 
was of 4.1 days, (SD ± 1.77), the average days since onset 
of symptoms until first medical attention according to 
the information contained in the medical records was 
5.72 days for cases (SD ± 4.45 days) and 5.60 for controls 
(SD ± 4.97 days). From the total sample, 71 % (43) of the 
cases and 45  % (54) of the controls were referred from 
other institutions where they received their first medical 
attention. Hospitals providing basic medical care, first-
level institutions were found to be the main medical 
institutions 90.7 %.
Forty-four cases were confirmed to be P. falciparum 
(73 %) and 16 P. vivax (26 %). For controls, 87 were con-
firmed P. falciparum (72 %) and 33 P. vivax (27 %).
In the medical records, evidence was found that 27 % of 
the cases and 19 % of the controls took medication with-
out prescription before admission to hospital. The most 
common medications found to be used by the patients 
were home-made remedies (12 %) and analgesics (87 %). 
From the total sample, 29 % of cases and 16 % of controls 
had a known medical condition at admission (co-morbid-
ities), the most common being gastritis (10), high blood 
pressure (5), asthma (4), urinary tract infection (4), and 
diabetes (3).
Physical examination at the time of admission
As shown in Table 3, there were no statistically significant 
differences between cases and controls regarding tem-
perature, respiratory rate, heart rate, or blood pressure. 
In the neurologic examination, 98.33 % (59) of the cases 
Table 2 Demographic characteristics of the population
Control Case
N % N %
Age
<5 12 10 1 1.67
5–9 13 10.83 4 6.67
10–14 19 15.83 8 13.33
15–19 13 10.83 11 18.33
20–29 17 14.17 18 30
30–39 26 21.67 6 10
40–49 7 5.83 8 13.33
>50 13 10.83 4 6.67
Sex
Male 64 53.33 30 50
Female 56 46.67 30 50
Healthcare affiliation
Affiliated 112 93.34 54 90
Not affiliated 8 6.67 6 10
Table 3 Difference in  the average of  vital signs and  its 
statistical significance thereof at  the time of  admission 
in cases and controls
P value using mean difference between sample data pairs
Signs Parameter Case Control P
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were found to be alert at the time of admission compared 
to 100 % for the controls; 3.4 % (two) and 2.7 % (three) of 
the cases and controls, respectively, were found to have 
intolerance to the oral route; 37 % (20) of the cases and 
9 % (nine) of the controls presented jaundice at the time 
of admission; 19 % (nine) of the cases presented physical 
signs of hepatomegaly compared to 4  % (three) for the 
controls; four (8 %) cases presented with splenomegaly at 
the time of admission. Dark urine was presented by 7/60 
of cases and four of 120 controls, haemorrhagic manifes-
tations were seen in two cases (3 %). The main haemor-
rhagic manifestation was epistaxis.
Laboratory findings
Table 4 shows the laboratory findings at the time of admis-
sion; no significant differences were found between cases 
and controls regarding haemoglobin levels, haematocrit, 
leucocyte count or parasitic count. The platelet count was 
found to have a significant difference between cases and 
controls. Statistically significant differences were also found 
between the cases and controls hepatic function tests, the 
average total bilirubin value and aspartate aminotrans-
ferase (AST) and alanine aminotransferase (ALT) values 
were found to be different between the two groups.
Severity findings
The most prevalent severity finding in the cases group 
was clinical jaundice as described above, followed by ele-
vated bilirubin 15/15 cases (25 %) and elevated transami-
nases 12/27 (44  %). Thrombocytopaenia was found in 
11/44 cases (20 %) and only five of 60 patients (8 %) pre-
sented severe anaemia.
Table 5 presents the severity signs at time of admission 
in the cases. In the bivariate analysis the variables that 
showed significant association were chills, dark urine, 
platelet count, clinical jaundice, and referral from a lower 
level facility to a higher level. Other variables, such as 
co-morbidities tachycardia, signs of respiratory distress, 
haemorrhagic manifestations, anaemia, showed associa-
tion but were not significant. The multivariate analysis 
showed that a platelet count <100,000 and clinical jaun-
dice were not associated with organ failure, and were 
the two variables associated with severe malaria in the 
patients described (Table 6).
Regarding the neurological signs and symptoms, only 
one patient presented with loss of consciousness, and 
one patient presented with multiple seizures; no data was 
available regarding the presence of signs of prostration 
or inability to feed oneself. Few patients presented with 
respiratory complications: three patients showed signs of 
respiratory distress syndrome and one had evidence of 
pulmonary oedema through radiography.
Table 4 Difference in the mean average of laboratory find-
ings and its statistical significance at the time of admission 
in cases and controls
P value using mean difference between sample data pairs
N* number of medical records with data available
Signs Parameter Case Control P
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There was no data available to determine the presence 
of metabolic acidosis, or hyperlactataemia. Further infor-
mation about severity findings at the time of admission is 
presented in Table 6.
Discussion
Malaria mortality and severity in Colombia, especially 
in the Pacific region, has maintained a decreasing trend 
given the improvement in knowledge of the population 
and from the health providers regarding early symptoms 
and malaria prevention, as well as more coverage and 
access to early diagnosis and treatment [7].
During the last decade the Pacific area has received 
help from the Global Fund for AIDS, the US National 
Institute of Allergy and Infectious Diseases, the Colom-
bian Ministry of Social Protection and National Institute 
of Health, which has significantly contributed to a reduc-
tion in malaria transmission and mortality, given educa-
tion and training of health personnel and communities 
[7, 9]. However, it has been described in the literature 
and confirmed in this study that patients are diagnosed 
with malaria approximately 72  h after symptom onset, 
which may be explained by the difficulties of access to 
healthcare facilities in the area, and to poverty and armed 
conflict present in areas of high transmission, which is 
adversely affecting malaria control efforts [7, 8].
In this study, the adult population was found to be 
affected in greater proportion than other age groups: 
only 11 % of the sampled patients were under 5 years of 
age, as has previously been described in the literature [8, 
9]. The working adult, economically active population 
is the most affected, given that the area is known for its 
mining and fish farming activities with the presence of 
permanent mosquito breeding sites [7].
Even though the patients analysed in this study had 
severity criteria that classified them as having severe or 
complicated malaria, the severity of the signs and symp-
toms was not as high as described in areas of Africa or 
Asia. The literature proposes clinical immunity to malaria 
in low-transmission settings to be one of the reasons for 
this phenomenon [9]. The Colombian literature reports 
that 17 % of the patients have presented multiple malaria 
episodes [8, 10]. Although this study aimed to describe 
this situation, the medical records reviewed did not have 
sufficient data, 43/60 cases and 76/120 of the controls 
did not have information available, which is the reason 
why this variable was not included in the multivariate 
analysis.
In Colombia, the diagnosis of severe malaria before 
2010 was made using the criteria established by the 
WHO; however in this year the Colombian Ministry of 
Health created a document based on the literature to 
adapt the criteria for the Colombian population, which 
included more conservative criteria, such as anaemia 
(haemoglobin  <7  g/dL in adults and children), renal 
dysfunction (serum creatinine  >1.5  mg/dL), severe 
thrombocytopaenia (≤50,000 platelets/μL), and hyper-
parasitaemia (>50,000 parasites/μL), and this is currently 
been used by healthcare professionals in the country to 
diagnose severe malaria [8]. However, most studies pub-
lished on malaria in Colombia use a combination of both 
WHO and Colombian guidelines to analyse their patients 
[9]. Colombian guideline criteria were used in this study 
with an adaptation of the transaminase level two times 
the normal, aiming to analyse the extent of hepatic dys-
function in the population. However, data regarding liver 
function test were limited, and no statistically significant 
difference was found in patients with altered hepatic 
Table 5 Factors associated with severity in malaria found in bivariated and multivariated analysis results
Variable OR Confidence interval Adjusted OR Confidence interval
Remitted 3.79 1.75 8.21
Chills 3.44 1.14 10.42
Dark urine 3.49 1.02 11.95
Platelet count <100,000 11.83 3.53 39.59 9.41 2.52 35.08
Clinical jaundice 4 1.72 9.24 3.85 1.43 10.34
Co-morbidities 1.93 0.87 4.26
Tachycardia 1.36 0.63 2.91
Temperature >38.7 °C 0.78 0.37 1.66
Dehydration 0.75 0.34 1.63
Signs of respiratory distress 3.23 0.58 17.99
Haemorrhagic manifestations 8.58 0.98 74.9
Anaemia 1.47 0.72 2.99
Creatinine 1.23 0.4 3.77
AST 1.77 0.28 11.21
ALT 5.46 0.59 4.94
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function and severity of malaria. Factors found to be 
associated with severe malaria in this study were plate-
let count <100,000 and clinical jaundice without evidence 
of organ failure. Low platelet count, hepatic failure and 
severe anaemia, among others, have been reported in 
Colombian studies to be the main malaria complications 
in Colombia [8].
As described in the literature, thrombocytopae-
nia is common in severe malaria cases in Colombia; 
in most cases a mild to moderate thrombocytopaenia 
(50,000–150,000 platelets/μL) is seen and generally does 
not represent a risk of spontaneous bleeding [9]. In the 
Colombian national malaria guidelines, severe throm-
bocytopaenia is considered when platelet counts are less 
than 50,000/mm3 [6], which was found in 11 cases of the 
present study. Platelet counts of less than 100,000/mm3 
were found to be a factor associated with severe malaria, 
and were described in 30 cases, with an odds ratio (OR) 
of 9.41 IC 95 % (2.52; 35.08).
Jaundice was another factor found to be associated with 
severe malaria in the present study, and it is important to 
point out that cases found to have jaundice had no organ 
damage or dysfunction, which suggests that jaundice is a 
relevant clinical sign in patients where severe malaria is 
suspected [6, 11].
Severe anaemia significantly contributes to malaria 
mortality. The literature reports that mild to moderate 
anaemia in the majority of the population is related to 
malnutrition or intestinal parasites and other conditions 
related to poverty. In this study, 85 patients presented 
with haemoglobin levels  <12  g/dL, considered as anae-
mia for both men and women, but two patients presented 
with haemoglobin levels less than 7  g/dL, i.e., severe 
anaemia and a criterion of severe malaria [12].
Cerebral malaria was not observed in this study, and its 
incidence has been reported to be low in Colombia [9].
Limited data are available regarding the association 
between malaria severity and co-morbidities, as opposed 
to infectious co-morbidities. In this study, no associa-
tion was found between them: OR 1.93 CI (0.87; 4.26). 
In the population studied, ten cases and 17 controls were 
found to have self-medicated with home-made remedies 
and over-the-counter analgesics before seeking medical 
attention. This needs to be further analysed in other stud-
ies, given its possible relation to the time of consultation 
of patients.
Differences between species regarding the prevalence 
of thrombocytopaenia, cerebral malaria and other sever-
ity criteria have been described in the literature, however 
no conclusion or analysis between species was made in 
Table 6 The signs of severity found in cases at time of admission
Severity signs at the time of admission Present Absent
N % N %
Loss of consciousness or profound coma 2 3.30 58 96.70
Prostration; extreme weakness with inability to walk or sit without assis-
tance
No data available No data available 60 100
Inability to feed oneself No data available No data available 60 100
Multiple seizures; more than 1 episode in 24 h 1 1.70 59 98.30
Respiratory distress syndrome 3 5.00 57 95.00
Spontaneous haemorrhage 2 3.30 58 96.30
Circulatory collapse/Shock SAP <80 mmHg (adults) SAP <50 mmHg 
(children)
4 6.70 56 93.30
Pulmonary oedema evidenced through radiography 1 1.7 59 98.30
Jaundice 33 27.5 87 72.5
Haemoglobinuria 1 1.70 59 98.30
Severe anaemia (Haemoglobin <7 g/dL, haematocrit <21 %) 5 8.30 55 91.70
Hypoglycaemia (glycaemia <60 mg/dL) 2 3.30 58 96.70
Metabolic acidosis (plasmatic bicarbonate <15 mmol/L) No data available No data available No data available No data available
Hyperlactaemia (lactate acid >5 mmol/L) No data available No data available No data available No data available
Renal insufficiency (serum creatinine level >1.5 mg/dL) 6 10.00 54 90.00
Hyperparasitaemia (>50,000 asexual parasites/μL) 4 6.70 56 96.30
Thrombocytopaenia <50,000 mm3 11 20.0 44 80.0
Elevated transaminase AST >80 IU 12 44.4 15 55.5
Elevated trasaminase ALT >80 IU 12 44.4 15 55.5
Elevated total bilirubin (>1.5 mg/dL) 15 25.0 No data available No data available
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this study given that a match by species was made as part 
of the design of the study.
The literature regarding the characteristics of com-
plicated malaria in Colombia is limited, there is a broad 
spectrum of clinical manifestations, and there is no 
information regarding multiple infections and the devel-
opment of immunity, association of severity signs with 
different Plasmodium species, characterization of the 
affected population, or the treatment options available. 
Most studies available are retrospective and developed in 
the Pacific area. More studies that describe the current 
situation and contribute to characterization of compli-
cated malaria in patients in Colombia are needed [8, 9].
It is of utmost importance for health personnel spe-
cially physicians to identify the red flags for severe 
malaria, described in the Colombian literature as danger 
signs. Changes in mental status, seizures, jaundice, bleed-
ing among others have been described as danger signs 
and should be detected early in order to prevent com-
plications and mortality associated with malaria. In this 
study, jaundice was found to be the main sign associated 
with severity in the population studied, and it is well-rec-
ognized as a danger sign in the Colombian literature.
Even though platelet count severity criteria for the 
Colombian Guidelines and WHO are 50.000 and 20.000/µL, 
respectively, in this study having platelet counts less than 
100.000/µL was found to be a significant danger sign [13].
Limitations
The research was rigorous, following the methodology 
described and as mentioned there were three reviewers 
of the data, however one of the weaknesses is that it was 
a retrospective study, there were difficulties in collect-
ing data, there was a lack of quality of medical records 
by omission of relevant clinical data in patients attend-
ing consultation for malaria. The data collection was 
first programmed to be done in specific municipalities 
selected in Colombia, based in the information of areas 
of higher transmission but due to administrative issues 
this was not possible. The data collection was limited to 
the municipality of Tumaco where medical records were 
available. Buenaventura Hospital was closed down during 
the research process which made it impossible to access 
medical records. In Cali, most of the patients were found 
to have non-complicated malaria, and there were few 
medical records that had severity criteria and were con-
sidered cases to pair with the controls.
Conclusion
The data collected form the medical records reviewed 
showed that most cases of malaria that occur in the pop-
ulation, despite meeting criteria of severity, have been 
shown to be not as morbid or severe as in other countries. 
The study showed that jaundice and thrombocytopaenia 
are associated with severe malaria, and they can be used 
with other signs and symptoms by general practitioners 
or primary care physicians to promptly identify patients 
to may progress towards clinical complications.
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